{"a": [["Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study", "2006"], ["Pioglitazone for diabetes prevention in impaired glucose tolerance", "2011"], ["Report of the expert committee on the diagnosis and classification of diabetes mellitus", "1997"], ["Report of the expert committee on the diagnosis and classification of diabetes mellitus", "2003"], ["Standards of medical care in diabetes \u2010 2008", "2008"], ["Diagnosis and classification of diabetes mellitus", "2010"], ["Standards of medical care in diabetes\u20102015", "2015"], ["Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy", "2006"], ["Pharmacologic prevention or delay of type 2 diabetes mellitus", "2005"], ["The ten\u2010year follow\u2010up of the Bedford survey (1962\u20101972): glucose tolerance and diabetes", "1982"], ["Designing psycho\u2010oncology randomised trials and cluster randomised trials: variance components and intra\u2010cluster correlation of commonly used psychosocial measures", "2013"], ["Are systematic reviews up\u2010to\u2010date at the time of publication?", "2013"], ["Can oral hypoglycemic agents restore normoglycemia in individuals with insulin resistance?", "2010"], ["Meglitinide analogues for type 2 diabetes mellitus", "2007"], ["Meglitinide analogues: a review of clinical data focused on recent trials", "2006"], ["Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex\u2010specific parental effects", "1996"], ["Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial", "2014"], ["Apparently conclusive meta\u2010analyses may be inconclusive \u2010 Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta\u2010analyses", "2009"], ["2014 National Diabetes Statistics Report", "2015"], ["The utility of fasting glucose for detection of prediabetes", "2006"], ["Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool", "2014"], ["Evaluating non\u2010randomised intervention studies", "2003"], ["Fasting hyperglycemia in non\u2010insulin\u2010dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake", "1989"], ["Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin", "2002"], ["10\u2010year follow\u2010up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study", "2009"], ["Convert whole blood results to plasma readings", "2016"], ["Blood sugar converter", "2016"], ["Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial", "2008"], ["Glimepiride", "2016"], ["Gliclazide 80 mg tablets", "2016"], ["Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta\u2010analysis", "2014"], ["Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study", "2014"], ["Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance", "2001"], ["Low positive predictive value of hemoglobin A1c for diagnosis of prediabetes in clinical practice", "2014"], ["GRADEproGDT", "2015"], ["Comparative tolerability of sulphonylureas in diabetes mellitus", "2000"], ["Dipeptidyl\u2010peptidase (DPP)\u20104 inhibitors or glucagon\u2010like peptide (GLP)\u20101 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus", "2016"], ["Sodium\u2010glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus", "2016"], ["Quantifying heterogeneity in a meta\u2010analysis", "2002"], ["Measuring inconsistency in meta\u2010analysis", "2003"], ["A re\u2010evaluation of random\u2010effects meta\u2010analysis", "2009"], ["Sequential methods for random\u2010effects meta\u2010analysis", "2011"], ["Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011", "2011"], ["The Cochrane Collaboration's tool for assessing risk of bias in randomised trials", "2011"], ["Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta\u2010analysis of randomised controlled clinical trials", "2011"], ["Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors", "2013"], ["International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice //1997 CFR &amp; ICH Guidelines", "USA: Barnett International/PAREXEL, 1997"], ["IDF Diabetes Atlas", "2013"], ["International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes", "2009"], ["Beta\u2010cell function is a major contributor to oral glucose tolerance in high\u2010risk relatives of four ethnic groups in the U.S", "2002"], ["The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews", "2010"], ["Discrete sequential boundaries for clinical trials", "1983"], ["The PRISMA statement for reporting systematic and meta\u2010analyses of studies that evaluate interventions: explanation and elaboration", "2009"], ["Industry sponsorship and research outcome", "2012"], ["Comparison of registered and published primary outcomes in randomized controlled trials", "2009"], ["Clinical review of glimepiride", "2001"], ["A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation", "2014"], ["Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study", "2002"], ["Progression rates from HbA1c 6.0\u20106.4% and other prediabetes definitions to type 2 diabetes: a meta\u2010analysis", "2013"], ["Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group", "1979"], ["Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis", "2012"], ["Mitiglinide for type 2 diabetes treatment", "2013"], ["Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta\u2010analysis", "2012"], ["Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta\u2010analysis", "1997"], ["Review Manager (RevMan)", "2014"], ["Interpretation of random effects meta\u2010analyses", "2011"], ["Meta\u2010analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data", "2013"], ["Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study", "2012"], ["Ten\u2010year follow\u2010up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation", "1980"], ["Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study", "2011"], ["Repaglinide: a review of its use in type 2 diabetes mellitus", "2012"], ["Racial differences in glycemic markers: a cross\u2010sectional analysis of community\u2010based data", "2011"], ["Recommendations for examining and interpreting funnel plot asymmetry in meta\u2010analyses of randomised controlled trials", "2011"], ["A study of the effects of hypoglycemic agents on vascular complications in patients with adult\u2010onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide", "1976"], ["Intensive blood\u2010glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group", "1998"], ["Effect of intensive blood\u2010glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group", "1998"], ["Alpha\u2010glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose", "2006"], ["Predisease: when does it make sense?", "2011"], ["Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate", "2008"], ["Trial sequential analysis may establish when firm evidence is reached in cumulative meta\u2010analysis", "2008"], ["Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation", "1998"], ["Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus", "1999"], ["Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation", "2006"], ["Comparison of top\u2010performing search strategies for detecting clinically sound treatment studies and systematic reviews in MEDLINE and EMBASE", "2006"], ["Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE", "2006"], ["Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta\u2010epidemiological study", "2008"], ["The epidemic of pre\u2010diabetes: the medicine and the politics", "2014"]], "ex": [["Low\u2010dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose", "2003"], ["The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia", "1988"], ["Short\u2010term treatment of glucose intolerance in middle\u2010aged subjects by diet, exercise and sulfonylurea", "1985"], ["The impact of treatment on insulin release and relative peripheral resistance during the oral glucose tolerance test. A study of noninsulin\u2010dependent diabetes mellitus and glucose intolerance", "1986"], ["Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early\u2010stage diabetic patients", "2012"], ["No effect of exenatide or sitagliptin therapy on beta\u2010cell secretory capacity in early type 2 diabetes", "2013"], ["The effects of nateglinide following oral glucose load in impaired glucose tolerance subjects: rapid insulin stimulation by nateglinide in IGT subjects", "2002"], ["Visceral fat metabolic activity is independently associated with coronary artery inflammation in patients with impaired glucose intolerance or type 2 diabetes", "2014"], ["Acarbose controls postprandial hyperproinsulinemia in non\u2010insulin dependent diabetes mellitus", "1997"], ["No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes", "2005"], ["[Effects of mitiglinide in treatment of impaired glucose tolerance]", "2005"], ["The NEPI antidiabetes study (NANSY). 1: short\u2010term dose\u2010effect relations of glimepiride in subjects with impaired fasting glucose", "2001"], ["Effects of acute and chronic attenuation of postprandial hyperglycemia on postglucose\u2010load endothelial function in insulin resistant individuals: is stimulation of first phase insulin secretion beneficial for the endothelial function?", "2008"], ["Treatment of mild gestational diabetes with glyburide versus placebo", "2016"], ["A comparison between two oral hypoglycemics \u2010 metformin and glybenclamide for the treatment of gestational diabetes mellitus", "2016"], ["Acute effect of glipizide on glucose tolerance in obesity and diabetes mellitus (NIDDM)", "1991"], ["[Effect of glibenclamide therapy on carbohydrate and lipid metabolism and insulin secretion in patients with glucose tolerance disorders : a 5\u2010year study]", "1981"], ["The effect of long\u2010term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance", "1983"], ["Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population", "2002"], ["Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance", "2006"], ["The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy\u2010living advice in subjects with increased but not diabetic fasting plasma glucose", "1997"]], "in": [["Long\u2010term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance", "2006"], ["Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)", "2011"], ["Novartis clinical result database \u2010 NAVIGATOR", "2011"], ["Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes", "2004"], ["Can life\u2010styles of subjects with impaired glucose tolerance be changed? A feasibility study", "1992"], ["Short term effects (2 years) of oral treatment for diabetes in the borderline impairment of oral glucose tolerance test", "1974"]]}